drugset
drugset / Trial / NCT02744690

Mitomycin C Trabeculectomy Trial for Glaucoma in Ethiopia

NCT02744690 ↗

Withdrawn University of California, San Francisco Menelik II Hospital · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is a randomized, double-masked trial to examine the response to trabeculectomy surgery. In this study, patients will be randomized to receive MMC via subconjunctival injection or topical sponge application.

Timeline

Start
2015-03-01
Primary completion
2019-03-01
Completion
2019-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitomycin C Other / unclassified 0.2 mg/ml Topical

Indications

glaucoma